Pulmonary embolism is
the sudden blockage of a major blood vessel (artery) in the lung, usually by a
blood clot. In most cases, the clots are small and are not deadly, but they
can damage the lung. But if the clot is large and stops blood flow to the lung,
it can be deadly. Quick treatment could save your life or reduce the risk of
future problems.
What are the symptoms?
The most common symptoms
are:
Sudden shortness of breath.
Sharp chest pain that is worse when you cough or take a deep
breath.
A cough that brings up pink, foamy mucus.
Pulmonary embolism can also cause more general symptoms.
For example, you may feel anxious or on edge, sweat a lot, feel lightheaded or
faint, or have a fast heart rate or
palpitations.
If you have symptoms like
these, you need to see a doctor right away, especially if they are sudden and
severe.
What causes pulmonary embolism?
In most cases,
pulmonary embolism is caused by a blood clot in the leg that breaks loose and
travels to the lungs. A blood clot in a vein close to the skin is not likely to
cause problems. But having blood clots in deep veins (deep vein thrombosis) can lead to pulmonary embolism.
Other things
can block an artery, such as tumors, air bubbles,
amniotic fluid, or fat that is released into the blood
vessels when a bone is broken. But these are rare.
What increases your risk of pulmonary embolism?
Anything that makes you more likely to form blood clots increases your
risk of pulmonary embolism. Some people are born with blood that clots too
quickly. Other things that can increase your risk include:
Being inactive for long periods. This can
happen when you have to stay in bed after surgery or a serious illness, or when
you sit for a long time on a flight or car trip.
Recent surgery
that involved the legs or belly.
Some diseases, such as cancer,
heart failure,
stroke, or a severe infection.
Pregnancy and childbirth (especially if you had a
cesarean section).
You are also at higher risk for blood clots if you are an
older adult (especially older than 70) or extremely overweight (obese).
How is pulmonary embolism diagnosed?
It may be
hard to diagnose pulmonary embolism, because the symptoms are like those of
many other problems, such as a
heart attack, a
panic attack, or
pneumonia. A doctor will start by doing a physical
exam and asking questions about your past health and your symptoms. This helps
the doctor decide if you are at high risk for pulmonary embolism.
Based on your risk, you might have tests to look for blood clots or rule
out other causes of your symptoms. Common tests include blood tests,
ultrasound, spiral
CT scan,
electrocardiogram (EKG), and
MRI.
How is it treated?
Doctors usually treat pulmonary
embolism with medicines called
anticoagulants. They are often called blood thinners,
but they don't really thin the blood. They help prevent new clots and keep
existing clots from growing.
At first, the doctor may give you a
shot of heparin, a blood thinner that works quickly. Then you may take warfarin
(such as Coumadin), a blood thinner that you take as a pill. Most people take
warfarin for a few months. People at high risk for blood clots may need it for
the rest of their lives.
If symptoms are severe and
life-threatening, "clot-busting" drugs called thrombolytics may be used. These
medicines can dissolve clots quickly, but they increase the risk of serious
bleeding. Another option is surgery to remove the clot (embolectomy).
Some people can't take blood thinners, or they form clots in spite of
taking the medicine. To prevent future problems, they may have a filter put
into the large vein (vena cava) that carries blood from the lower body to the
heart. A
vena cava filter helps keep blood clots from reaching
the lungs.
If you have had pulmonary embolism once, you are more
likely to have it again. Blood thinners can help reduce your risk, but they
increase your risk of bleeding. If your doctor prescribes blood thinners, be
sure you understand how to take your medicine safely, and see your doctor for
regular blood tests.
You can reduce your risk of pulmonary
embolism by doing things that help prevent blood clots in your legs.
Avoid sitting for long periods. Get up and
walk around every hour or so, or flex your feet often.
Get moving
as soon as you can after surgery.
When you travel, drink extra
fluids. But avoid drinks with alcohol or caffeine.
Wear
compression stockings if you are at high risk.
If you take blood
thinners, take them just the way your doctor tells you to.
Pulmonary embolism is caused by a blocked artery in the lungs. The most common
cause of such a blockage is a blood clot that forms in a
deep vein in the leg and travels to the lungs, where
it becomes lodged in a smaller lung artery.
Over 95% of blood
clots that cause pulmonary embolism are formed in the
deep leg veins.1 Clots also can form in the deep
veins of the arms or pelvis.
Occasionally blood clots develop in
surface veins, but these clots rarely lead to
pulmonary embolism.
In rare cases, pulmonary embolism may be
caused by other substances, including:2
Small masses of infectious
material.
Fat, which can be released into the bloodstream after
some types of bone fractures, surgery, trauma, or severe burns.
Air
bubbles from trauma, surgery, or medical procedures.
Amniotic fluid
from normal or complicated pregnancy and childbirth (very rare).
Tumors caused by rapidly growing cancer cells.
Foreign
substances-such as a catheter that can break off during a medical procedure,
talc, mercury, iodine, cotton, or the growth of tapeworm larvae.
Pulmonary embolism may be difficult to diagnose because its
symptoms may occur with or are similar to other conditions, such as a
heart attack, a
panic attack, or
pneumonia. Also, some people with pulmonary embolism
do not have symptoms.
If a large blood clot blocks
the artery in the lung, blood flow may be completely stopped, causing sudden
death. A smaller clot reduces the blood flow and may cause damage to lung
tissue. But if the clot dissolves on its own, it may not cause any major
problems.
Symptoms of
pulmonary embolism usually begin suddenly. Reduced
blood flow to one or both lungs can cause shortness of breath and a rapid heart
rate. Inflammation of the tissue covering the lungs and chest wall (pleura) can
cause sharp chest pain.
Without treatment, pulmonary embolism is
likely to come back.
Doctors will consider aggressive steps when they are
treating a large, life-threatening pulmonary embolism. Death caused by
pulmonary embolism usually occurs within 30 minutes of the onset of
symptoms.3
Chronic or recurring pulmonary embolism
Blood clots that cause
pulmonary embolism may dissolve on their own. But if you have had pulmonary
embolism, you have an increased risk of a repeat episode if you do not receive
treatment. If pulmonary embolism is diagnosed promptly, treatment with
anticoagulant medicines (usually heparin and warfarin)
may prevent new blood clots from forming.
The risk of having
another pulmonary embolism caused by something other than blood clots varies.
Substances that are reabsorbed into the body, such as air, fat, or amniotic
fluid, usually do not increase the risk of having another episode. Cancer
increases the risk of blood clots.
Having multiple episodes of
pulmonary embolism can severely reduce blood flow through the lungs and heart.
Over time, this increases blood pressure in the lungs (pulmonary hypertension),
eventually leading to right-sided
heart failure and possibly
death.
For more information on risk factors for
blood clots in the legs, see the topic Deep Vein Thrombosis.
Risk
factors for developing clots include having slowed blood flow, abnormal
clotting, and a blood vessel injury.
Slowed blood flow
When blood does not circulate
normally, clots are more likely to develop. Reduced circulation may result
from:
Long-term bed rest, such as if you are
confined to bed after an operation, injury, or serious
illness.
Traveling and sitting for a long time, especially when
traveling long distances by airplane.4
Leg paralysis. When you use your muscles, the muscles contract,
and that squeezes the blood vessels in and around the muscles. The squeezing
helps the blood move back toward the heart. Paralysis can reduce circulation
because the muscles cannot contract.
Abnormal clotting
Some people have blood that
clots too easily or too quickly. People with this problem are more likely to
form larger clots that can break loose and travel to the lungs. Conditions that
may cause increased clotting include:
Inherited factors. Some people have an
inherited tendency to develop blood clots that can lead to pulmonary
embolism.
Use of birth control pills or other medicines that
contain estrogen or estrogen-like hormones, such as those some women take for
hormone replacement therapy during menopause.2
Heavy smoking.
Injury to the blood vessel wall
Blood is more
likely to clot in veins and arteries shortly after they are injured. Injury to
a vein can be caused by:
Major surgery involving the legs, abdomen, or
pelvis.
A tube (catheter) placed in a large vein of the body
(central venous catheter).
Other risk factors include:
Pregnancy. A woman's risk for
developing blood clots increases both during pregnancy and shortly after
delivery.
Age. As people get older (especially older than age 70),
they are more likely to develop blood clots.
Weight. Being
overweight increases the risk for developing clots.
Call 911 or other emergency services immediately if you think you have symptoms of
pulmonary embolism. Symptoms include:
Sudden shortness of breath.
Sharp
chest pain that sometimes becomes worse with deep breathing or
coughing.
Rapid pulse or
palpitations.
Sweating.
Anxiety.
A cough
that may produce bloody mucus or blood.
Fainting.
Call your doctor right away if you have
symptoms of a blood clot in the leg. These symptoms may include:
Swelling in a leg that may make it noticeably
larger than the other leg. Swelling may also appear as a swollen ridge along a
blood vessel that you can feel.
Skin that is red and warm to the
touch.
Pain or tenderness in the calf or thigh. Some people only
notice pain when standing or walking.
Blood clots in the deep veins of the leg are the most
common cause of pulmonary embolism. For more information on these types of
blood clots, see the topic Deep Vein Thrombosis.
Watchful Waiting
If you think you may have pulmonary embolism,
call your doctor or go to the emergency room at the nearest hospital. Watchful
waiting is not appropriate for pulmonary embolism.
Who To See
Health professionals who can diagnose pulmonary embolism include:
Diagnosis depends on an
accurate and thorough
medical history and ruling out other conditions. Your
doctor will need to know about your symptoms and
risk factors for pulmonary embolism, such as having recent surgery or having
a prior history or family history of blood clots. This information, combined
with a careful
physical exam, will point to the initial tests that
are best suited to diagnose a
deep vein thrombosis or pulmonary embolism.
Tests that are often done if you have shortness of breath or chest pain
include:
A
chest X-ray. Results may rule out an enlarged heart or
pneumonia as a cause of your symptoms. If the chest
X-ray is normal, you may need further testing.
Electrocardiogram (EKG, ECG). The electrical activity
of the heart is recorded with this test. EKG results will help rule out a
possible heart attack.
D-dimer. A D-dimer blood test measures
a substance that is released when a blood clot breaks up. D-dimer levels are
usually high in people with pulmonary embolism.
Ventilation-perfusion scanning. This
test scans for abnormal blood flow through the lungs after a radioactive tracer
has been injected and you breathe a radioactive gas.
Pulmonary angiogram. A pulmonary angiogram (also
called a pulmonary arteriogram) is the most accurate way to diagnose pulmonary
embolism. This test is not available at some smaller hospitals and is more
invasive than other testing.
Computed tomography (CT) angiogram. A CT angiogram uses a special dye and a series of X-rays
to produce pictures of blood vessels. It can be done to look for a pulmonary
embolism or for a blood clot that may cause a pulmonary embolism.
Doppler ultrasound. A Doppler ultrasound test uses
reflected sound waves to determine whether a blood clot is present in the large
veins of the legs.
Echocardiogram (echo). This test detects abnormalities in the size or function of the
heart's right ventricle, which may be an indicator of pulmonary
embolism.
After your doctor has determined that you have a pulmonary
embolism, other tests can help guide treatment and suggest how well you will
recover. These tests may include:
A blood test to check the level of the hormone
brain natriuretic peptide (BNP). Higher levels of BNP
mean your heart is under increased stress.
A blood test to look at
the level of the protein
troponin. Higher levels of troponin can mean there is
damage to your heart muscle.
Treatment Overview
Treatment of
pulmonary embolism focuses on preventing future
pulmonary embolism by using
anticoagulant medicines. Anticoagulants prevent
existing blood clots from growing larger and help prevent new ones from
developing.
If symptoms are severe and life-threatening,
immediate and sometimes aggressive treatment is needed. Aggressive treatment
may include
thrombolytic medicines, which can dissolve a blood
clot quickly but also increase the risk of severe bleeding. Another option for
life-threatening, large pulmonary embolism is surgical removal of the clot,
called an embolectomy. This surgery is only available at a few large
hospitals.
Some people may also benefit from having a
vena cava filter inserted into the large central vein
of the body. This filter can help prevent blood clots from reaching the lungs.
It is used when anticoagulants are not an option, when clots form despite
anticoagulant use, or when there is an increased risk of death or a severely
restricted lifestyle if another pulmonary embolism occurs.
Prevention
Daily use of
anticoagulant medicines may help prevent recurring
pulmonary embolism by stopping new blood clots from
forming and stopping existing clots from growing.
The risk of
forming another blood clot is highest in the weeks after the first episode of
pulmonary embolism. This risk decreases over time. But the risk remains high
for months and sometimes years, depending upon what caused the pulmonary
embolism. People with recurrent blood clots and/or pulmonary embolism may have
to take anticoagulants daily for the rest of their lives.5 Anticoagulant medicines also are often used for people who
are not active due to illness or injury, or people who are having surgery on
the legs, abdomen, or pelvis.6
Other
preventive methods may also be used, such as:
Getting you moving shortly after
surgery.
Wearing
compression stockings to help prevent leg deep vein
thrombosis if you are at increased risk for this condition.
Aspirin may reduce the risk of forming blood clots.7 Aspirin, however, is not adequate for treating pulmonary
embolism.
You are at higher risk for blood clots when you are
traveling because of long periods of inactivity.8 To
help prevent blood clots during travel:9
Wear compression stockings if you are at risk
for deep vein thrombosis.
Get up and walk around every half hour to
an hour.
Pump your feet up and down by pulling your toes up toward
your knees then pointing them down.
Drink extra
fluids.
Wear loose-fitting clothes that are not tight around your
waist or your legs.
Avoid drinks that have alcohol or caffeine in them, because they
cause you to lose fluids. Caffeine is found in coffee, tea, and many
sodas.
Take a dose of low-molecular-weight heparin (LMWH) if your doctor
recommends it because you are at high risk for blood clots.
Home Treatment
Home treatment is not recommended for
initial treatment for
pulmonary embolism. But it is important for preventing
additional clots from developing and causing a
deep vein thrombosis, which can lead to recurring
pulmonary embolism.
Measures that reduce your risk for developing
a deep vein thrombosis include the following:
Exercise. Keep blood moving in your legs by
pointing your toes up toward your head so that your calves are stretched, then
relaxing. Repeat. This exercise is especially important when you are sitting
for long periods of time, for example, on long driving trips or airplane
flights.
Get up out of bed as soon as possible after an illness or
surgery. It is very important to get moving as soon as you are able. If you
cannot get out of bed, do the leg exercises described above every hour to keep
the blood moving through your legs.
Quit smoking. This is
especially important if you are using any medicines that contain estrogen, such
as birth control pills.
Wear
compression stockings to help prevent leg deep vein
thrombosis if you are at increased risk for this condition.
For more information on how to prevent clots from
developing, see the topic
Deep Vein Thrombosis.
Medications
Medicines can help prevent repeated
episodes of
pulmonary embolism by preventing new blood clots from
forming or preventing existing clots from getting larger.
Medication Choices
Anticoagulants are prescribed when pulmonary embolism
is diagnosed or strongly suspected. Normally, when an injury that causes
bleeding occurs, the body sends out signals that cause the blood to clot at the
wound. The clot naturally breaks down as the wound heals. A person who is prone
to abnormal clotting has an imbalance between clot formation and clot
breakdown. Anticoagulants prevent the production of certain proteins that are
necessary for blood to clot. Although anticoagulants can prevent new clots from
forming and prevent existing clots from getting larger, they do not break up or
dissolve existing blood clots.
Heparin and warfarin are the two
main types of anticoagulants used to treat pulmonary embolism.
Heparin
Heparin is an anticoagulant
given by injection. It immediately affects the clotting system in your body.
Oral anticoagulant medicine (warfarin) takes longer to start working.
Initial treatment with a
low-molecular-weight heparin (LMWH) usually is preferred because it can be
given as an injection once or twice per day, and it may be given at home,
allowing you to leave the hospital earlier. Blood tests are not usually needed
to monitor LMWH's clotting effect.
Unfractionated heparin is
another form that can be used. It is given in the hospital. Unfractionated
heparin is usually given continuously through your vein (intravenously, or IV),
but can also be given as an injection under the skin. Frequent blood tests
(usually every 6 hours) are required to monitor the clotting effects of this
medicine.1
Studies show that LMWH is more effective than
unfractionated heparin for:10
Reducing the risk of another pulmonary
embolism.
Lowering the risk of death 3 to 6 months after starting
treatment.
Both forms of heparin can cause severe bleeding in some
people. But if bleeding occurs, unfractionated heparin can be stopped quickly,
whereas LMWH has to wear off.
Warfarin(such as Coumadin)
Warfarin is an anticoagulant that is
taken in pill form. It is usually started while a person is still being treated
with heparin because it takes several days for warfarin to build up to a level
that's effective. When the warfarin is at a proper level, heparin is
discontinued and treatment with warfarin continues. Studies show that warfarin
reduces the risk of another blood clot.11
Typically, warfarin is given for at least 3 to 6 months or longer after
pulmonary embolism to reduce the risk of having another blood clot. Treatment
with anticoagulants may continue throughout your life if the risk of having
another pulmonary embolism remains high.
For those people with
ongoing risk factors, such as cancer, anticoagulant treatment continues as long
as those risk factors are present. Some people with inherited blood-clotting
disorders or a history of recurrent deep vein thrombosis or pulmonary embolism
may take oral anticoagulants for the rest of their lives.
Because warfarin can increase the risk of birth defects,
pregnant women with pulmonary embolism are limited to
taking heparin. A few days after the baby is born, a woman can switch from
heparin to warfarin.
Thrombolytics
Clot-dissolving (thrombolytic) medicines are not
commonly used to treat pulmonary embolism. Although they can quickly dissolve a
blood clot, thrombolytics also greatly increase the risk of serious bleeding.
They are occasionally used to treat a life-threatening pulmonary
embolism.
What To Think About
After pulmonary embolism is
diagnosed, a doctor considers:
Whether anticoagulant medicines are
appropriate.
How long anticoagulants should be used.
If you have recently had a major stroke, surgery, or
active internal bleeding, you usually cannot take anticoagulant or thrombolytic
medicines. A
vena cava filter may help to reduce the risk of
another pulmonary embolism in this case.
It's important that you
keep the following safety tips in mind when taking warfarin.
Safety tips for anticoagulants
Take the medicine at the same time each
day.
Check with your doctor before using
over-the-counter drugs, especially ones that contain
aspirin.
Tell any new health professionals that you are taking
medicine that affects how your blood clots.
Be alert for signs of
bleeding, and call the doctor immediately if any of the following symptoms
occur:
Blood in your urine, or red stools, or
black stools that look like tar
Nosebleeds that are hard to
stop
Spitting up blood
New, excessive, or prolonged
vaginal bleeding
Frequent, severe bruising or tiny red or purple
spots on the skin
Talk to your doctor about medicines you are
taking to find out how often you should have blood tests.
If you take warfarin (such as Coumadin):
Get regular blood tests to ensure that you
are taking the right amount of medicine.
Eat a balanced diet. It is
most important to maintain a consistent level of vitamin K foods in your diet.
Vitamin K can interfere with the action of warfarin, making it more likely that
your blood will clot. For more information, see:
Avoid excessive use of alcohol. If you drink,
do so only in moderation. Chronic drinking may cause liver damage and increase
the effect of warfarin.
Don't use tobacco of any kind.
Avoid activities that have a high risk for injury, such as skiing,
football, or other contact sports. If you are taking warfarin, an injury could
result in excessive bleeding.
Wear a seat belt anytime you are
traveling in a car.
Preventing minor bleeding while taking anticoagulants
You may find it helpful to use the following items to lower your risk of
bleeding:
An electric razor
A
soft-bristled toothbrush and waxed floss
Protective clothing, such
as gloves and shoes
Nonslip mats in the tub and shower
Surgery
Surgical removal of a clot is called an
embolectomy. This type of treatment for
pulmonary embolism is rarely used. It is considered
for people who cannot have other kinds of treatment or those whose clot is so
dangerous that they cannot wait for medicine to work. An embolectomy also may
be an option for a person whose condition is stable but who shows signs of
significant reduced blood flow in the pulmonary artery.
What to Think About
Surgery increases the risk of
forming new blood clots that can cause another pulmonary embolism.
Other Treatment
Some people cannot take
anticoagulant medicines, or they continue to develop blood clots despite taking
the medicines. If surgery or medicines are not options, other methods of
preventing
pulmonary embolism may be considered, such as a vena
cava filter.
Other Treatment Choices
A
vena cava filter may be inserted in the large central
vein that passes through the abdomen and returns blood from the body to the
heart (vena cava). This filter can prevent blood clots in the leg or pelvic
veins from traveling to the lungs and heart. These filters may be permanent or
removable.
Studies have shown that vena cava filters help prevent
pulmonary embolism. But they may be most effective when combined with
anticoagulant therapy.
What To Think About
Vena cava filters are not
recommended as the first treatment for pulmonary embolism. But they may be
considered if you:
Continue to have pulmonary embolism despite
taking anticoagulant medicine.
Cannot take anticoagulants because
of bleeding risk.
Have an increased risk of death or a severely
restricted lifestyle should another pulmonary embolism occur.
Vena cava filters may benefit people who have had a
pulmonary embolism surgically removed (embolectomy) if another pulmonary
embolism would likely be fatal or severely limit a person's lifestyle.
Vena cava filters can cause serious health problems if they become
blocked with one or more blood clots.
Vena cava filters have not
been shown to lower the death rate in people with pulmonary embolism.
Other Places To Get Help
Organizations
American Heart Association (AHA)
7272 Greenville Avenue
Dallas, TX 75231
Phone:
1-800-AHA-USA1 (1-800-242-8721)
Web Address:
www.americanheart.org
Call the American Heart Association (AHA) to find your
nearest local or state AHA group. AHA can provide brochures and information
about support groups and community programs, including Mended Hearts, a
nationwide organization whose members visit people with heart problems and
provide information and support. AHA's Web site also has information on
physical activity, diet, and various heart-related conditions.
American Venous Forum
203 Washington Street, PMB #311
Salem, MA 09170
Phone:
(978) 744-5005
Fax:
(978) 744-5029
E-mail:
venous-info@administrare.com
Web Address:
http://www.venous-info.com/
The mission of the American Venous Forum is to improve the care of
patients with vein and lymph disorders by providing a forum for education and
the exchange of information about basic and clinical research in the venous and
lymphatic systems. The Web site offers an online book entitled The Layman's Handbook of Venous Disorders that explains basic
terms and treatment options and offers answers to frequently asked
questions.
National Heart, Lung, and Blood Institute
(NHLBI)
P.O. Box 30105
Bethesda, MD 20824-0105
Phone:
(301) 592-8573
Fax:
(240) 629-3246
TDD:
(240) 629-3255
E-mail:
nhlbiinfo@nhlbi.nih.gov
Web Address:
www.nhlbi.nih.gov
The U.S. National Heart, Lung, and Blood Institute (NHLBI)
information center offers information and publications about preventing and
treating heart, lung, and blood diseases.
Tapson VF (2008). Pulmonary embolism. In L Goldman, D
Ausiello, eds., Cecil Medicine, 23rd ed., pp. 688-696.
Philadelphia: Saunders Elsevier.
Task Force for the Diagnosis and Management of Acute
Pulmonary Embolism, European Society of Cardiology (2008). Guidelines on the
diagnosis and management of acute pulmonary embolism. European Heart Journal, 29: 2276-2315. Available online:
http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-APE-FT.pdf.
American College of Obstetricians and Gynecologists
(2007). Prevention of deep vein thrombosis and pulmonary embolism. ACOG
Practice Bulletin No. 84. Obstetrics and Gynecology,
110(2): 429-440.
Lapostolle F, et al. (2001). Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345(11): 779-783.
Buller HR, et al. (2004). Antithrombotic therapy for
venous thromboembolic disease: Seventh ACCP conference on antithrombotic and
thrombolytic therapy. Chest, 126(3 Suppl):
401S-428S.
Kearon C, Hirsh J (2007). Pulmonary embolism section
of Venous thromboembolism. In DC Dale, DD Federman, eds., ACP Medicine, section 1, chap. 18. New York: WebMD.
Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2002). Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin: Pulmonary embolism prevention (PEP) trial. Lancet, 355(9212): 1295-1302.
Abramowicz M, ed. (2006). Advice for travelers.
Treatment Guidelines from the Medical Letter, 4(45):
25-34.
Hirsch J, et al. (2008). Executive summary: American
College of Chest Physicians evidence-based clinical practice guidelines (8th
ed.). Chest, 133(6): 71-109.
McManus RJ, Fitzmaurice D (2007). Thromboembolism,
search date September 2006. Online version of BMJ Clinical Evidence. Also available online:
http://www.clinicalevidence.com.
Kearon CK, et al. (2003). Comparison of low-intensity
warfarin therapy with conventional-intensity warfarin therapy for long-term
prevention of recurrent venous thromboembolism. New England Journal of Medicine, 349(7): 631-639.
Other Works Consulted
Agency for Healthcare Research and Quality (2003).
Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism. Evidence Report/Technology Assessment No. 68. (AHRQ
Publication No.03-E012). Rockville, MD: Agency for Healthcare Research and
Quality.
Fedullo PF (2008). Pulmonary embolism. In V Fuster et
al., eds., Hurst's The Heart, 12th ed., pp. 1649-1672.
New York: McGraw-Hill Medical.
Tapson VF, Becker RC (2007). Venous thromboembolism.
In EJ Topol et al., eds., Textbook of Cardiovascular Medicine, 3rd ed., pp. 1569-1584. Philadelphia: Lippincott Williams and
Wilkins.
Wood KE (2002). Major pulmonary embolism: Review of a
pathophysiologic approach to the golden hour of hemodynamically significant
pulmonary embolism. Chest, 121(3): 877-905.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Tapson VF (2008). Pulmonary embolism. In L Goldman, D
Ausiello, eds., Cecil Medicine, 23rd ed., pp. 688-696.
Philadelphia: Saunders Elsevier.
Task Force for the Diagnosis and Management of Acute
Pulmonary Embolism, European Society of Cardiology (2008). Guidelines on the
diagnosis and management of acute pulmonary embolism. European Heart Journal, 29: 2276-2315. Available online:
http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-APE-FT.pdf.
American College of Obstetricians and Gynecologists
(2007). Prevention of deep vein thrombosis and pulmonary embolism. ACOG
Practice Bulletin No. 84. Obstetrics and Gynecology,
110(2): 429-440.
Lapostolle F, et al. (2001). Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345(11): 779-783.
Buller HR, et al. (2004). Antithrombotic therapy for
venous thromboembolic disease: Seventh ACCP conference on antithrombotic and
thrombolytic therapy. Chest, 126(3 Suppl):
401S-428S.
Kearon C, Hirsh J (2007). Pulmonary embolism section
of Venous thromboembolism. In DC Dale, DD Federman, eds., ACP Medicine, section 1, chap. 18. New York: WebMD.
Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2002). Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin: Pulmonary embolism prevention (PEP) trial. Lancet, 355(9212): 1295-1302.
Abramowicz M, ed. (2006). Advice for travelers.
Treatment Guidelines from the Medical Letter, 4(45):
25-34.
Hirsch J, et al. (2008). Executive summary: American
College of Chest Physicians evidence-based clinical practice guidelines (8th
ed.). Chest, 133(6): 71-109.
McManus RJ, Fitzmaurice D (2007). Thromboembolism,
search date September 2006. Online version of BMJ Clinical Evidence. Also available online:
http://www.clinicalevidence.com.
Kearon CK, et al. (2003). Comparison of low-intensity
warfarin therapy with conventional-intensity warfarin therapy for long-term
prevention of recurrent venous thromboembolism. New England Journal of Medicine, 349(7): 631-639.